โ… . Introduction

  • CIAV๋Š” 2~4์ฃผ๋ น ๋‹ญ์—์„œ ๋‹ค๋ฐœ (ํ์‚ฌ์œจ ์ฆ๊ฐ€, ๋นˆํ˜ˆ, ๋ฆผํ”„๊ตฌ ๊ฐ์†Œ, ํ‰์„  ์œ„์ถ•, ๊ฐ„ ๋ณ€ํ™”, ํ”ผํ•˜์ถœํ˜ˆ)
    • multipotent cell์— ์ž‘์šฉํ•˜์—ฌ ์ ํ˜ˆ๊ตฌ์™€ ๋ฆผํ”„๊ตฌ์˜ ๋ถ„ํ™” ์–ต์ œ โ†’ macrophage, T cell, B cell, Dendritic cell ๋“ฑ์ด X
    • thymus atropy : T cell์ด ๋ถ„ํ™”ํ•˜์ง€ ์•Š์œผ๋ฏ€๋กœ ์œ„์ถ•
    • liver change : RBC๊ฐ€ ์ ์–ด์„œ ์ฐฝ๋ฐฑํ•˜๊ฒŒ ๋ณ€ํ™”
    • subcutaneous hemorrhage : ์ง€ํ˜ˆ ์ธ์ž์˜ ๋ถ„ํ™” ์–ต์ œ โ†’ ์กฐ๋ฅ˜๋Š” ๊ธฐ๋ณธ์ ์œผ๋กœ ๋ฏธ์„ธ์ถœํ˜ˆ์ด ๋งŽ์€๋ฐ, ์ž‘์€ ์ถœํ˜ˆ์—๋„ ์ง€ํ˜ˆ์ด ๋˜์ง€ ์•Š์Œ
  • [pancytopenia|pancytopenia] ์œ ๋ฐœ : ์ ํ˜ˆ๊ตฌ, ๋ฐฑํ˜ˆ๊ตฌ, ํ˜ˆ์†ŒํŒ ๊ฐ์†Œ
    • ๋ฉด์—ญ ์–ต์ œ(๋ฐฑํ˜ˆ๊ตฌX), ์ถœํ˜ˆ์ฆํ›„๊ตฐ(์ง€ํ˜ˆ์ธ์žX), ์žฌ์ƒ๋ถˆ๋Ÿ‰์„ฑ ๋นˆํ˜ˆ(์ ํ˜ˆ๊ตฌX) ๋“ฑ ์œ ๋„

Multipotent stem cell

  • Myeloid progenitor : ์ ํ˜ˆ๊ตฌ, ๊ณผ๋ฆฝ๊ตฌ, ํ˜ˆ์†ŒํŒ์œผ๋กœ ๋ถ„ํ™”
  • Lymphoid progenitor : B cell, T cell๋กœ ๋ถ„ํ™”
  • CIAV๊ฐ€ ์ „๊ตฌ์ฒด๋ฅผ ๋ง‰์•„๋ฒ„๋ฆฌ๋ฏ€๋กœ ์ ํ˜ˆ๊ตฌ, ๋ฐฑํ˜ˆ๊ตฌ, ํ˜ˆ์†ŒํŒ / B cell, T cell ๋‹ค ์ƒ์‚ฐ ์•ˆ๋จ
  • age/sex/breed dependent (์—ฐ๋ น๊ฐ์ˆ˜์„ฑ์˜ ํŒจํ„ด)
    • myeloid progenitor๋Š” 4์ฃผ๋ น์— ๋ถ„ํ™” ์™„๋ฃŒ๋จ โ‡’ ๋นˆํ˜ˆ(anemia), ์ง€ํ˜ˆ์žฅ์• (hemorrhagic syndrome) : 4์ฃผ ์ด์ „
    • lymphoid progenitor๋Š” 10-15์ฃผ๋ น์— ๋ถ„ํ™” ์™„๋ฃŒ๋จ โ‡’ ๋ฉด์—ญ ์–ต์ œ(immunosupression) : 10-15์ฃผ๋ น ์ด์ „
  • ์ˆ˜ํƒ‰์ด ์•”ํƒ‰์— ๋น„ํ•ด ์˜ˆ๋ฏผํ•จ : ์„ฑ๋ณ„๋ณด๋‹ค๋Š” ์ฒด์ค‘ ๋•Œ๋ฌธ (์ˆ˜ํƒ‰>์•”ํƒ‰)
  • immunosuppression์— ์˜ํ•œ ํ˜ผํ•ฉ๊ฐ์—ผ(co-infection) ๊ฐ€๋Šฅ, ์น˜์‚ฌ์œจ ์ฆ๊ฐ€
  • Myeloid๋ณด๋‹ค lymphoid progenitor๊ฐ€ ๊ฐ์ˆ˜์„ฑ ๋†’์Œ โ‡’ ๋ฐ”์ด๋Ÿฌ์Šค ์ ๊ฒŒ ํˆฌ์—ฌํ•  ๊ฒฝ์šฐ, ๋ฉด์—ญ ์ €ํ•˜๋Š” ๋ฐœ์ƒ, ๋นˆํ˜ˆ๊นŒ์ง€๋Š” ๋ฐœ์ƒX
  • ์–ด๋ฆด ๋•Œ๋Š” ํ•ญ์ฒด ๋ถ„ํ™”๊ฐ€ ๋งŽ์œผ๋ฏ€๋กœ ์˜ํ–ฅ์ด ํฌ์ง€๋งŒ, ๋‚˜์ด๊ฐ€ ๋“ค์ˆ˜๋ก ๋ถ„ํ™”์‹œํ‚ค๋Š” ์–‘์ด ์ค„์–ด๋“ค์–ด ์˜ํ–ฅ์ด ๋œํ•จ.
  • vertical transmission : ์–ด๋ฏธ ๋‹ญ์€ ๋ฉ€์ฉกํ•ด๋„ ์ˆ˜์ง๊ฐ์—ผ๋˜์–ด ์ž์†์—์„œ ์‹ฌ๊ฐํ•œ ์˜ํ–ฅ์„ ๋‚˜ํƒ€๋‚ผ ์ˆ˜ ์žˆ์Œ.
  • ๊ฒฝ์ œ์  ์†ํ•ด
    • ์ฆ์ฒด์œจ ์ €ํ•˜, ํ์‚ฌ์œจ ์ฆ๊ฐ€
    • ๋ฉด์—ญ ์–ต์ œ โ†’ ๋‹ค๋ฅธ ์งˆ๋ณ‘์˜ ๊ฐ์ˆ˜์„ฑ ์ฆ๊ฐ€
    • CIAV๋ฅผ ๊ฐ€์ง„ ์ฑ„ ํƒœ์–ด๋‚˜๋ฉด ๋ฐฑ์‹ ์— ๋Œ€ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘ ๋ถˆ๊ฐ€ โ†’ ํ•ญ์ฒด ํ˜•์„ฑ ๋ถˆ๊ฐ€
  • Synonyms
    • Blue wing (ํ”ผํ•˜์ถœํ˜ˆ)
    • Infectious anemia, Hemorrhagic syndrome, Chicken anemia agent(CAA)
    • Anemia dermatitis syndrome (Clostridium perfringens๊ฐ€ ์ฆ์‹ํ•˜์—ฌ ๊ดด์ €์„ฑ ํ”ผ๋ถ€์—ผ ์œ ๋ฐœ)
    • Chicken anemia virus (CAV, ๊ณต์‹ ๋ช…์นญ)

โ…ก. Etiology

1) Classification

  • family Circoviridae
    • genus Gyrovirus * genus Circovirus์™€ ํ•ญ์›์ ์œผ๋กœ ๋ฌด๊ด€, tropism ๋‹ค๋ฆ„

2) Properties

  • ssDNA, circular, 2.3kb (๋งค์šฐ ์ž‘์Œ) icosahedral ๊ตฌ์กฐ, ์ง๊ฒฝ 25-26.5nm
  • ๊ตฌ์กฐ ๋‹จ๋ฐฑ์งˆ : VP1, VP2, VP3
    • VP1 : Neutralizing epitope์„ ๊ฐ€์ง€๋ฉฐ, ๋ถ€์ฐฉ ์—ญํ• .
      • VP2์˜ ๋„์›€์„ ๋ฐ›์•„์•ผ ๋‹จ๋ฐฑ์งˆ ๊ตฌ์กฐ๋ฅผ ํ˜•์„ฑํ•  ์ˆ˜ ์žˆ์Œ, VP1 +VP2 ๊ฐ™์ด ์žˆ์–ด์•ผ ๋ณ‘์›์„ฑ ๊ฐ€๋Šฅ.
    • VP2 : VP1 ๊ตฌ์กฐ ํ˜•์„ฑ์„ ๋„์›€.
    • VP3(apoptin) : apoptosis๋ฅผ ์œ ๋„.
  • non-envelope ์ค‘์—์„œ๋„ ๋งค์šฐ ๊ฐ•ํ•œ ํŽธ. ์ €ํ•ญ์„ฑ์ด ๊ฐ•ํ•จ.
    • ์—ด, pH, ์‚ด๊ท ์ œ ์ €ํ•ญ์„ฑ์ด ๋†’์Œ. (๋ฝ์Šค๊ฐ€ ์œ ์ผํ•˜๊ฒŒ ํšจ๊ณผ์ ^[80โ„ƒ 15๋ถ„, pH 3, Chloroform, ํฌ๋ฅด๋ง๋ฆฐ ๋“ฑ์—์„œ๋„ ์ƒ์กด.])

3) Replication

  • absorption, penetration์€ ์ผ๋ฐ˜์ ์ธ ๊ณผ์ •์„ ๋”ฐ๋ฆ„.
  • ๋ณต์ œ : rolling-circle-model. ์›ํ˜•์„ ๋”ฐ๋ผ๊ฐ€๋ฉด์„œ replication์ด ์ผ์–ด๋‚จ.
    • ์–ด๋ฆฐ ๋‹ญ์—์„œ CIAV๊ฐ€ ๊ฐ€์žฅ ์ž˜ ๋ณต์ œํ•˜๋Š” ์„ธํฌ : hematopoietic precursor cells (๊ณจ์ˆ˜์˜ ์กฐํ˜ˆ์ „๊ตฌ์„ธํฌ) > thymic precursor cells(ํ‰์„  ํ”ผ์งˆ์˜ ํ‰์„ ์ „๊ตฌ์„ธํฌ-precursor T cells) โ†’ VP3์— ์˜ํ•œ apoptosis๋ฅผ ์œ ๋„ํ•จ. โ‡’ ํ•˜์ง€๋งŒ B cell, T cell ๋ชจ๋‘ ์–ต์ œํ•œ๋‹ค๋Š” ์‚ฌ์‹ค์„ ๊ธฐ์–ต!
    • 3-6์ฃผ๋ น ๋‹ญ : 4์ฃผ๋ น์„ ๊ธฐ์ ์œผ๋กœ ์กฐํ˜ˆ์ „๊ตฌ์„ธํฌ์˜ ๋ถ„ํ™”๊ฐ€ ๊ฐ์ˆ˜ํ•˜๋ฏ€๋กœ, ํ‰์„  ํ”ผ์งˆ์—์„œ O, ๊ณจ์ˆ˜์—์„œ X

4) Strain Classification

  • 2๊ฐœ์˜ ํ˜ˆ์ฒญํ˜•์ด ์กด์žฌ
  • serotype 1์ด ์ค‘์š”ํ•œ ๋ณ‘์›์ฒด๋กœ์„œ ์ž‘์šฉ.

5) Laboratory host system

  • 1์ผ๋ น ๋ณ‘์•„๋ฆฌ์—์„œ ๊ฐ€์žฅ ๊ฐ์ˆ˜์„ฑ ๋†’์Œ.
    • ๋ฆผํ”„ ์กฐ์ง๊ณผ ๊ณจ์ˆ˜์—์„œ ๋นˆํ˜ˆ, ๋ณ‘๋ณ€.
    • CIAV์˜ ๋ณ‘์›์„ฑ์€ 1) Marekโ€™s disease์— ๋™์‹œ์— ๊ฑธ๋ฆฌ๊ฑฐ๋‚˜ 2) betamethasone(๋ฉด์—ญ ์–ต์ œํ•˜๋Š” ์Šคํ…Œ๋กœ์ด๋“œ)์„ ์ฒ˜์น˜ํ•˜๊ฑฐ๋‚˜ 3) bursectomized chicks(F๋‚ญ์„ ์ธ์œ„์ ์œผ๋กœ ์ œ๊ฑฐ)์ผ ๋•Œ ํ™•์—ฐํžˆ ์ฆ๊ฐ€ํ•จ.
    • ๋ชจ์ฒด์ดํ–‰ํ•ญ์ฒด๋ฅผ ๊ฐ€์งˆ ๊ฒฝ์šฐ ๊ฐ์—ผ์— ์ €ํ•ญ์„ฑ ์žˆ์Œ. ์‚ฐ๋ž€ ์ „์— ํ•ญ์ฒด๋ฅผ ์ถฉ๋ถ„ํžˆ ํ™•๋ณดํ•˜๋Š” ๊ฒŒ ์˜ˆ๋ฐฉ์— ์ œ์ผ ์ข‹์Œ.
  • ์„ธํฌ ๋ฐฐ์–‘ * MDCC(๋งˆ๋ ‰๋ณ‘์ด ํŠน์ • ์„ธํฌ์—์„œ ์ข…์–‘ํ™”๋œ ์„ธํฌ์ฃผ) โ†’ ์ข…์–‘ ์„ธํฌ๋ฅผ ์ œ์ž‘ํ•˜์—ฌ line ์ œ์ž‘

6) Pathogenecฤฑty

  • virulence
    • age-resistant๊ฐ€ ๊ฐ€์žฅ ์ค‘์š”
    • ์„ธํฌ๊ณ„๋Œ€๋ฐฐ์–‘์œผ๋กœ ํฌ์„
  • ๊ฐ์—ผ
    • ๋ณดํ†ต ์ผ์‹œ์ ์ด๋ฉฐ, ์ž ๋ณต๊ฐ์—ผ^[Infectious Laryngotracheitis , Marek] ์ด๋‚˜ ์ง€์†๊ฐ์—ผ X

โ…ข. Pathogenesis

1) Disease

  • CIAV โ†’ viremia โ†’ thymic atrophy, bone marrow hypoplasia โ†’ pancytopenia
  • age- & dose- dependent
    • ๋งค์šฐ ์–ด๋ฆฐ ๋ณ‘์•„๋ฆฌ(14์ผ๋ น ์ดํ•˜)๋Š” ๋นˆํ˜ˆ์— ๊ฐ€์žฅ ๊ฐ์ˆ˜์„ฑ ๋†’์Œ
    • ๋ชจ๋“  ์—ฐ๋ น์—์„œ ๊ฐ์—ผ ๊ฐ€๋Šฅํ•˜๋‚˜ 4์ฃผ ์ด์ƒ์—์„  anemia ๋‚˜ํƒ€๋‚˜์ง€ X
    • 10์ฃผ๋ น๊นŒ์ง€๋„ ๊ฐ์—ผ, ๊ฑธ๋ฆฌ๋ฉด Tcell์ด ๋งŽ์ด ๊ฐ์—ผ๋จ โ†’ immunosuppression
  • CIAV ๊ด€๋ จ / ์˜์กด ์งˆ๋ณ‘
    • CIAV-associated disease : CIAV ๋‹จ๋…์ด ์•„๋‹˜ (ex. ๋ฉด์—ญ ์–ต์ œ๋กœ ์ธํ•œ ์„ธ๊ท  ๊ฐ์—ผ)
    • CIAV-dependent disease : CIAV ๋‹จ๋… ์งˆ๋ณ‘(ex. ๋นˆํ˜ˆ, ํ”ผํ•˜ ์ถœํ˜ˆ)
    • ๋ชจ๋“  ์ฆ์ƒ์€ ๋ฐ”์ด๋Ÿฌ์Šค์— ์˜ํ•œ ๋ฉด์—ญ์–ต์ œ๋‚˜ ๋ฒ”ํ˜ˆ๊ตฌ๊ฐ์†Œ์ฆ์— ๊ธฐ์ธํ•œ๋‹ค.
    • ๊ฑฐ์˜ ๋Œ€๋ถ€๋ถ„ ๋‹ค๋ฅธ ์งˆ๋ณ‘๊ณผ ํ•จ๊ป˜ ๋‚˜ํƒ€๋‚จ.
      • ex. ์–ด๋ฆฐ ์—ฐ๋ น ๊ฐ์—ผ๋˜๋ฉด โ†’ HVT ๋ฉด์—ญ(๋งˆ๋ ‰๋ฐฑ์‹ )์ด ์–ต์ œ โ†’ ๋ฐฑ์‹ ์˜ ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ๋ณ‘์›์„ฑ์„ ๋‚˜ํƒ€๋‚ด vvMDV์™€ ๊ฐ™์€ ์˜ํ–ฅ์ด ๋ฐœ์ƒ
  • ์œก๊ณ„ (broiler)> ์ข…๊ณ„ pullet > ์‚ฐ๋ž€๊ณ„ pullet
    • ์—ฐ๋ น, ์ฒด์ค‘ ๊ด€๋ จ
    • ์œก๊ณ„๋Š” ์–ด๋ ค์„œ ๊ฐ์ˆ˜์„ฑ์ด ๋†’์Œ / ์ข…๊ณ„๊ฐ€ ์‚ฐ๋ž€๊ณ„๋ณด๋‹ค ๋ฌด๊ฑฐ์›€.
    • ์ˆ˜ํƒ‰ > ์•”ํƒ‰ (โ† ์ฒด์ค‘)
  • ์ข…๊ณ„ ์•”ํƒ‰์ด CIAV ๊ฐ์—ผ๋˜์—ˆ์„ ๋•Œ, ์ผ๋ถ€ ๋ณ‘์•„๋ฆฌ๋Š” 3-12์ฃผ๊ฐ„ ๋ฒ”ํ˜ˆ๊ตฌ๊ฐ์†Œ์ฆ ๋‚˜ํƒ€๋ƒ„ (๋‚œ๊ณ„๋Œ€๊ฐ์—ผ)

2) Clinical signs

  • ํŠน์ง•์ ์œผ๋กœ(only sign์€ ์•„๋‹˜) anemia - ์ ‘์ข… 14-16์ผ ํ›„ peak
    • ํ˜ˆ์•ก์—์„œ ์ ํ˜ˆ๊ตฌ ๊ฐ์†Œ, ๋ฌผ์ด ๋งŽ์•„์ง(watery), ์‘๊ณ  ์‹œ๊ฐ„ ์ง€์—ฐ, ์ฐฝ๋ฐฑ
    • hematocrit value(์ ํ˜ˆ๊ตฌ์šฉ์ ๋ฅ ) ๊ฐ์†Œ : ์ •์ƒ์ ์œผ๋กœ 27-35%์ธ๋ฐ, 6-27%๋กœ ๊ฐ์†Œ
  • morbidity(์ „์—ผ๋ฅ ) : 20-60% / mortality(์น˜์‚ฌ์œจ) : 5-10%

3) Gross lesions

  • ==ํ‰์„  ์œ„์ถ•์ด ๊ฐ€์žฅ ์ง€์†์ , ๊ณจ์ˆ˜ ์œ„์ถ•==๋„ ํŠน์ง•์ 
  • F๋‚ญ ์œ„์ถ•๋„ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ์Œ (๊ทธ๋Ÿฌ๋‚˜ B cell๋ณด๋‹ค T cell์„ ๋” ๊ณต๊ฒฉ)
  • ๊ณจ์ˆ˜์˜ ์‹ค์งˆ ์กฐ์ง์ด ์ง€๋ฐฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋˜๋ฉด์„œ ์—ฐํ•ด์ง - ๋ˆ„๋ ‡๊ฑฐ๋‚˜ ๋ถ„ํ™๋น›
  • ํ”ผํ•˜ ์ถœํ˜ˆ, ์ „์œ„ ์ถœํ˜ˆ
  • Blue wing (gangrenous dermatitis, ๊ดด์ €์„ฑ ํ”ผ๋ถ€์—ผ) : T cell ์–ต์ œ๋กœ ์ธํ•œ C. perfringens์˜ ๊ณผ์ฆ์‹, ํ”ผ๊ฐ€ ๋น ์ ธ๋‚˜๊ฐ€๊ณ  ๋‚˜๋ฉด ํ”ผ๋ฉ ๋“  ๊ฒƒ์ฒ˜๋Ÿผ ํ‘ธ๋ฅด๋”ฉ๋”ฉํ•จ)
  • ์ถœํ˜ˆ-์žฌ์ƒ๋ถˆ๋Ÿ‰์„ฑ ๋นˆํ˜ˆ ์ฆํ›„๊ตฐ(hemorrhagic-aplastic anemia syndrome) : ์ถœํ˜ˆ๊ณผ ๋นˆํ˜ˆ์ด ๋™์‹œ์— ๋ฐœ์ƒ
    • ์ดˆ๊ธฐ 3์ฃผ์— ๊ฐ€์žฅ anemia ์‚ฌ์ธ ์ž˜ ๋‚˜ํƒ€๋‚จ

โ…ฃ. Epizootiology

  • ์ˆ™์ฃผ๋Š” ๊ฑฐ-์˜ ๋‹ญ
  • horizontal transmission : ๋ถ„๋ณ€(major), ํ˜ธํก๊ธฐ, FFE^[๋งˆ๋ ‰๋ณ‘์—์„œ์˜ ์ฃผ ๊ฐ์—ผ ๊ฒฝ๋กœ]
  • vertical transmission : ์–‘๊ณ„ ์‚ฐ์—…์—์„œ ์ฃผ ํ”ผํ•ด ์›์ธ

โ…ค. Diagnosis

  • ์ˆ˜์ง ์ „ํŒŒ : blue wings๋กœ ์•Œ์•„๋ณด๊ธฐ ์‰ฌ์›€
  • ์ˆ˜ํ‰ ์ „ํŒŒ : ๋‹ค๋ฅธ ์งˆ๋ณ‘๊ณผ ๊ตฌ๋ถ„ํ•˜๊ธฐ ์–ด๋ ต์ง€๋งŒ, ๋นˆํ˜ˆ์ด ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์ฆํ‘œ

โ…ฅ. Prevention

  • 10-12์ฃผ ์ดํ›„ ๋ฐฑ์‹  ์ ‘์ข…, ํŠนํžˆ ์‚ฐ๋ž€ ์ „์— ๋ฐฑ์‹  ์ ‘์ข… (๊ฐ€์žฅ ์ข‹์€ ์ „๋žต : monitor breeder)